Clinical trial
Effectiveness of Blood Clot Medication With Concomitant Blood Pressure…
NCT00424281 · Wayne State University, Other · Unknown status
Key facts
| NCT number | NCT00424281 |
|---|---|
| Title | Effectiveness of Blood Clot Medication With Concomitant Blood Pressure Medication |
| Official title | Pharmacokinetics of Fondaparinux (Arixtra) to Critically Ill Patients on Vasopressor Therapy |
| Lead sponsor | Wayne State University, Other |
| Collaborators | GlaxoSmithKline Industry |
| Status | Unknown status |
| Study type | Observational |
| Conditions | ICU Patients 18 Years or Older. |
| Intervention type | Drug |
| Interventions | Arixtra (fondaparinux), 2.5 mg/day-what is bioavailability |
| Enrollment | 40 |
| Start date | Feb 1, 2007 |
| Completion | Jan 1, 2010 |
| First posted | Jan 19, 2007 |
| Last update posted | Jan 19, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: